SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002642
Filing Date
2019-04-26
Accepted
2019-04-26 17:25:28
Documents
4
Period of Report
2019-06-07
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238636zdef14a.htm DEF 14A 357781
2 G1003563.JPG g1003563.jpg GRAPHIC 17647
3 G27012BCI001.GIF g27012bci001.gif GRAPHIC 100103
4 G27012BCI002.GIF g27012bci002.gif GRAPHIC 60873
  Complete submission text file 0001047469-19-002642.txt   605338
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 19772944
SIC: 2834 Pharmaceutical Preparations